← Russell 3000 cross-section

DXCM DEXCOM INC

Trailing twelve months to 2026-06-30 · as filed 2026-07-30, not restated
Healthcare

Scale

Market cap
$34.0bn
Revenue TTM
$5.0bn
Net income TTM
$1,000m
Free cash flow
$1.4bn
Composite score
61.9
Sector rank
#310

Valuation

P / E
34.0
EV / EBITDA
23.4
EV / sales
6.6
FCF yield
4.13%
Earnings yield vs 10-yr
-1.79pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
20.1%
EBITDA margin
28.2%
ROE
38.1%
ROIC
75.1%
Revenue growth
15.5%

Insider activity, last 90 days

Net open-market
$-8.45m
Buyers
0
Sellers
6

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

There were no material changes to our critical accounting estimates during the six months ended June 30, 2026. We ended the second quarter of 2026 with cash, cash equivalents and short-term marketable securities totaling $1.95 billion. Revenue We generate our revenue from the sale of disposable sensors and reusable transmitters and receivers. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter.DEXCOM INC, 10-Q, period ended 2026-06-30, filed 2026-07-30

Read the full passage →